文献速递创伤骨科骨质疏松与代谢性骨病

髋部骨折后口服双膦酸盐使用轨迹:一项基于人群的队列研究

Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
PubMed 文献 · Osteoporos Int · 2024-01-10

该回顾性研究纳入澳大利亚维多利亚州2012至2017年首次髋部骨折后接受两次及以上双膦酸盐处方的≥50岁患者1811例,用组基轨迹模型识别12个月用药轨迹。结果66%持续依从,17%延迟配药,9%早期停药,9%晚期停药;入院前用药及高龄与延迟配药风险降低相关,男性焦虑及女性既往跌倒与早期停药风险升高相关。

要点

  • 髋部骨折后12个月内66%患者持续依从口服双膦酸盐,17%延迟配药,9%早期停药,9%晚期停药。
  • 入院前使用双膦酸盐者延迟配药风险降低(RR 0.28,95%CI 0.21-0.39)。
  • ≥85岁较50-64岁患者延迟配药风险降低(RR 0.38,95%CI 0.22-0.64)。

核心结论

  • 三分之二患者在髋部骨折后12个月内对口服双膦酸盐表现出良好依从性。
  • 作者认为进一步增加出院后抗骨吸收药物使用的努力应具有性别特异性,并解决对延迟开始治疗可能存在的持续不确定性。

研究设计与样本

  • 回顾性研究,纳入澳大利亚维多利亚州2012至2017年所有≥50岁、首次髋部骨折后接受两次及以上双膦酸盐处方的患者,共1811例。
  • 使用组基轨迹模型对12个月口服双膦酸盐使用轨迹进行分类,并用多变量多项逻辑回归评估与不同轨迹相关的因素。

主要发现

  • 在1811例患者中识别出四种口服双膦酸盐使用模式:持续依从66%、延迟配药17%、早期停药9%、晚期停药9%。
  • 入院前使用双膦酸盐与两性中延迟配药风险降低相关(相对风险[RR] 0.28,95%置信区间[CI] 0.21-0.39)。
  • 较年长患者(≥85岁 vs 50-64岁)延迟配药风险降低(RR 0.38,95%CI 0.22-0.64)。
  • 男性伴焦虑者早期停药风险升高(RR 9.80,95%CI 2.24-42.9)。
  • 女性有既往跌倒史者早期停药风险升高(RR 1.80,95%CI 1.16-2.78)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Bisphosphonates prevent future hip fractures. However, we found that one in six patients with hip fractures had a delay in bisphosphonate initiation and another one-sixth discontinued treatment within 12 months after discharge. Our results highlight the need to address hesitancy in treatment initiation and continuous monitoring. PURPOSE: Suboptimal antiresorptive use is not well understood. This study investigated trajectories of oral bisphosphonate use following first hip fractures and factors associated with different adherence and persistence trajectories. METHODS: We conducted a retrospective study of all patients aged ≥ 50 years dispensed two or more bisphosphonate prescriptions following first hip fracture in Victoria, Australia, from 2012 to 2017. Twelve-month trajectories of bisphosphonate use were categorized using group-based trajectory modeling. Factors associated with different trajectories compared to the persistent adherence trajectory were assessed using multivariate multinomial logistic regression. RESULTS: We identified four patterns of oral bisphosphonate use in 1811 patients: persistent adherence (66%); delayed dispensing (17%); early discontinuation (9%); and late discontinuation (9%). Pre-admission bisphosphonate use was associated with a lower risk of delayed dispensing in both sexes (relative risk [RR] 0.28, 95% confidence interval [CI] 0.21-0.39). Older patients ( ≥ 85 years old versus 50-64 years old, RR 0.38, 95% CI 0.22-0.64) had a lower risk of delayed dispensing. Males with anxiety (RR 9.80, 95% CI 2.24-42.9) and females with previous falls had increased risk of early discontinuation (RR 1.80, 95% CI 1.16-2.78). CONCLUSION: Two-thirds of patients demonstrated good adherence to oral bisphosphonates over 12 months following hip fracture. Efforts to further increase post-discharge antiresorptive use should be sex-specific and address possible persistent uncertainty around delaying treatment initiation.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Leung MTY, Turner JP, Marquina C, et al. Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study. Osteoporos Int. 2024. PMID: 38195713. doi:10.1007/s00198-023-06974-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。